Mouse anti Human LEF-1 alternate exon

CAT:
579-X1075M
Size:
100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Mouse anti Human LEF-1 alternate exon - image 1

Mouse anti Human LEF-1 alternate exon

  • Background:

    Lymphoid Enhancer Factor-1 (LEF-1) is an HMG 1/2-like DNA binding/bending protein and is a member of the LEF/TCF transcription factor family. There are four LEF/TCF family members in mammalian systems (LEF-1, TCF-1, TCF-3 and TCF-4), and orthologs to these factors have been identified in many different species. LEF/TCFs are downstream mediators of Wnt/Wingless signals. Wnt signaling drives cell polarity, cell fate and cell growth decisions in embryonic tissues and in post-natal tissues that continue to develop from mitotically active stem cell precursors. Misregulation of Wnt signaling is also implicated as a root cause of many different cancers, such as colon cancer, melanoma, breast cancer, prostate cancer and others. This antibody is specific for an epitope between a.a. 227-231. This sequence lies within the context dependent activation domain of LEF-1 and appears to be an alternate splice variant exon of the LEF-1 gene
  • Synonyms:

    Mouse Anti Lef-1, Lymphoid Enhancer Factor 1
  • UniProt:

    Q9UJU2
  • Host:

    Mouse
  • Species Reactivity:

    Human
  • Isotype:

    IgG1
  • Clone:

    1C3
  • Conjugation:

    Unconjugated
  • Type:

    Monoclonal Antibody
  • Applications:

    WB
  • Field of Research:

    Signal Transduction
  • Purification Method:

    Protein A/G Chromatography
  • Assay Principle:

    Detect LEF-1 protein containing the alternately spliced exon between amino acids 212-241 by Western blot at 1-5 µg/mL. Optimal concentration should be evaluated by serial dilutions.
  • Stability:

    See expiration date on vial
  • Concentration:

    See vial for Concentration
  • Form:

    Provided as solution in phosphate buffered saline with 0,08% sodium azide
  • Precautions:

    This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving Humans or animals.
  • References & Citations:

    1. Riese, J., et al., LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 1997, 88, 777-787 2. Giese, K., et al. Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1. Proc. Natl. Acad. Sci. USA 1997, 94, 12845-12850 3. Behrens, J., et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382, 638-642 4. Giese, K. and Grosschedl, R. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 1993, 12, 4667-4676 5. Hovanes, K., et al., The Human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res. 2000, 28, 1994-2003
  • Shipping Conditions:

    Ambient Temperature, freeze upon arrival
  • Storage Conditions:

    Product should be stored at -20ºC; Aliquot to avoid freeze/thaw cycles
  • Functional Analysis:

    WB
  • CAS Number:

    9007-83-4